Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 2 , Pages 323-338 , June 2007

The kinetics of thyroid hormone transporters and their role in non-thyroidal illness and starvation

  • Georg Hennemann, MD, PhD, FRCP, FRCPE (Internist)

      Affiliations

    • Corresponding Author InformationCorresponding author. Offenberglaan 1, app 1a, 2594 BM The Hague, The Netherlands. Fax: +31 70 3817917.

References 

  1. Singh SP, Carter AC, Kydd DM, et al. Interaction between thyroid hormones and erythrocyte membranes: Competitive inhibition of binding 131I-L-triiodothyronine and 131I-L-thyroxine by their analogues. Endocrine Research Communications. 1978;3:119–131
  2. Tata JR. How specific are ‘nuclear’ receptors for thyroid hormones?. Nature. 1975;257:18–23
  3. Gharbi-Chini J, Torresani J. Thyroid hormone binding to plasma membrane preparations: studies in different thyroid states and tissues. Journal of Endocrinological Investigations. 1981;4:177–183
  4. Felicetta JV, Czanko R, Huber-Smith MJ, et al. Cholecystographic agents and sulfobromophthalein inhibit the binding of L-thyroxine to plasma membranes of rat hepatocytes. Endocrinology. 1986;18:2500–2504
  5. Gharbi J, Torresani J. High affinity thyroxine binding to purified rat liver plasma membranes. Biochemical and Biophysical Research Communication. 1979;88:170–177
  6. Arnott RD, Eastman CJ. Specific 3,3′,5′-triiodothyronine (reverse T3) binding sites on rat liver plasma membranes: comparison with thyroxine (T4) binding sites. Journal of Receptor Research. 1983;3:393–407
  7. Botta JA, de Mendoza D, Morero RD, et al. High affinity L-triiodothyronine binding sites on washed rat erythrocyte membranes. Journal of Biological Chemistry. 1983;258:6690–6692
  8. Hennemann G, Docter R, Friesema ECH, et al. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocrine Reviews. 2001;22:451–476
  9. Angel RC, Botta , Farias RN. High affinity L-triiodothyronine binding to right-side-out and inside-out vesicles from human and rat erythrocyte membrane. Journal of Biological Chemistry. 1989;264:19143–19146
  10. Samson M, Osty J, Francon J, et al. Triiodothyronine binding sites in the rat erythrocyte membrane: involvement in triiodothyronine transport and relation to the tryptophan transport system T. Biochimica et Biophysica Acta. 1992;1108:91–98
  11. Alderson R, Pastan I, Cheng S. Characterization of the 3,3′,5-triiodo-L-thyronine-binding site on plasma membranes from human placenta. Endocrinology. 1985;116:2621–2630
  12. Horiuchi R, Johnson ML, Willingham MC, et al. Affinity labeling of the plasma membrane 3,3′,5-triiodo-L-thyronine receptor in GH3 cells. Proceedings of the National Academy of Sciences of the United States of America. 1982;79:5527–5531
  13. Cheng S. Structural similarities between the plasma membrane binding sites for L-thyroxine and 3,3′,5-triiodo-L-thyronine in cultured cells. Journal of Receptor Research. 1985;5:1–26
  14. Hasumura S, Kitagawa S, Lovelace E, et al. Characterization of a membrane-associated 3,3′,5-triiodo-L-thyronine binding by use of monoclonal antibodies. Biochemistry. 1986;25:7881–7888
  15. Kato H, Velu T, Cheng SY. High level expression of p55, a thyroid hormone binding protein which is homologous to protein disulfide isomerase in retroviral vector. Biochemical and Biophysical Research Communication. 1989;164:138–244
  16. Samson M, Osty J, Thibout H, et al. Solubilization, reconstitution and molecular properties of the triiodothyronine transport protein from rat erythrocyte membranes. European Journal of Endocrinology. 1996;134:660–668
  17. Mol JA, Krenning EP, Docter R, et al. Inhibition of iodothyronine transport into rat liver cells by a monoclonal antibody. Journal of Biological Chemistry. 1986;261:7640–7643
  18. Christensen HN, Hess B, Riggs TR. Concentration of taurine, β-alanine, and triiodothyronine by ascites carcinoma cells. Cancer Research. 1954;14:124–127
  19. Hogness JR, Lee ND, Berg MK, et al. The concentration and binding of thyroxine and triiodothyronine by rat diaphragm. Journal of Clinical Investigations. 1957;36:803–809
  20. Rao GS, Eckel J, Rao ML, et al. Uptake of thyroid hormone by isolated rat liver cells. Biochemical and Biophysical Research Communication. 1976;73:98–104
  21. Krenning EP, Docter R, Bernard HF, et al. Active transport of triiodothyronine (T3) into isolated rat liver cells. FEBS Letters. 1978;91:113–116
  22. Krenning EP, Docter R, Bernard B, et al. Decreased transport of thyroxine (T4), 3,3′,5- triiodothyronine (T3) and 3,3′,5′-triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs. FEBS Letters. 1982;140:229–233
  23. Krenning E, Docter R, Bernard B, et al. Characteristics of active transport of thyroid hormone into rat hepatocytes. Biochimica et Biophysica Acta. 1981;676:314–320
  24. Kaptein EM. Hormone specific alterations of T4, T3 and reverse T3 metabolism in ethanol abstinence in humans. American Journal of Physiology. 1997;272:E191–E200
  25. Jenning AS, Ferguson DC, Utiger RD. Regulation of the conversion of thyroxine to triiodothyronine in the perfused rat liver. Journal of Clinical Investigations. 1979;64:1614–1623
  26. de Jong M, Docter R, van der Hoek HJ, et al. Transport of T3 into the perfused rat liver and subsequent metabolism are inhibited by fasting. Endocrinology. 1992;131:463–470
  27. de Jong M, Docter R, Bernard HF, et al. T4 uptake into the perfused rat liver and liver T4 uptake in humans are inhibited by fructose. American Journal of Physiology. 1994;266:E768–E775
  28. Docter R, de Jong M, van der Hoek HJ, et al. Development and use of a mathematical two pool model of distribution and metabolism of 3,3′,5-triiodothyronine in a recirculating rat liver perfusion system: albumin does not play a role in cellular transport. Endocrinology. 1990;126:451–459
  29. de Jong M, Docter R, van der Hoek H, et al. Different effects of amiodarone on transport of T4 and T3 into the perfused rat liver. American Journal of Physiology. 1994;266:E44–E49
  30. Kassem NA, Deane R, Segal MB, et al. Role of transthyretin in thyroxine. transfer from cerebrospinal fluid to brain and choroid plexus. American Journal of Physiology Regulatory. Integrative and Comparative Physiology. 2006;291:R1310–R1315
  31. Hagen GA, Solberg LA. Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology. 1974;95:1398–1410
  32. Kaptein EM. Thyroid hormone metabolism in illness. In:  Hennemann G editors. Thyroid hormone metabolism. New York: Marcel Dekker; 1986;p. 297–333
  33. Krenning EP, Docter R, van Toor H, et al. Strategy of thyroid-function testing, a comparative study using TT4, FT4I, various FT4 and IRMA-TSH kits. Journal of Endocrinological Investigations. 1986;9 Suppl 4:95–104
  34. Bianco AC, Salvatore D, Gereben B, et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrinology Reviews. 2002;23:38–89
  35. Hennemann G, Krenning EP. Thyroid hormones. In:  Jenkins RC,  Ross RJM editor. The endocrine response to acute illness. Basel: Karger; 1999;p. 87–109
  36. Hennemann G. Non-thyroidal Illness. In:  Wass J,  Shalet S editor. Oxford Textbook of Endocrinology. Oxford, UK: Oxford University; 2001;p. 316–323
  37. Hennemann G, Visser TJ. Thyroid hormone synthesis, plasma membrane transport and metabolism. In:  Weetman AP,  Grossman A editor. Pharmacotherapeutics of the thyroid gland. Berlin: Springer; 1997;p. 75–117
  38. Bauer AGC, Wilson JHP, Lamberts SWJ, et al. Handling of iodothyronines by liver and kidney in patients with chronic liver disease. Acta Endocrinology (Copenhagen). 1987;116:339–346
  39. Kaptein EM, Robinson WJ, Grieb DA, et al. Peripheral serum thyroxine, triiodothyronine, and reverse triiodothyronine in the low thyroxine state of acute nonthyroidal illness. A noncompartmental analysis. Journal of Clinical Investigations. 1982;69:526–535
  40. Kaptein EM, Kaptein JS, Chang EI, et al. Thyroxine transfer and distribution in critical nonthyroidal illness, chronic renal failure, and chronic ethanol abuse. The Journal of Clinical Endocrinology and Metabolism. 1987;65:606–616
  41. Kaptein EM, Feinstein EI, Nicoloff JT, et al. Serum reverse triiodothyronine and thyroxine kinetics in patients with chronic renal failure. The Journal of Clinical Endocrinology and Metabolism. 1983;57:181–189
  42. Kaptein EM. Thyroid hormone metabolism and thyroid disease in chronic renal failure. Endocrinology Reviews. 1996;17:45–63
  43. Kaptein EM. Clinical relevance of thyroid hormone alterations in nonthyroidal illness. Thyroid International. 1997;4:22–25
  44. Krenning EP, Bernard HF, de Jong M, et al. Serum factors in severe non-thyroidal illness (NTI) inhibit metabolism of thyroid hormone. Annals of Endocrinology (Paris). 1986;47:58;(Abstract)
  45. Lim CF, Bernard HF, de Jong M, et al. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia. The Journal of Clinical Endocrinology and Metabolism. 1993;76:318–324
  46. Lim CF, Docter R, Visser TJ, et al. Inhibition of thyroxine transport into cultured rat hepatocytes by serum of non uremic critically-ill patients by bilirubin and non-esterified fatty acids. The Journal of Clinical Endocrinology and Metabolism. 1993;76:1165–1172
  47. Lim CF, Docter R, Krenning EP, et al. Transport of thyroxine into cultured hepatocytes: effects of mild non-thyroidal illness and caloric restriction in obese subjects. Clinical Endocrinology (Oxford). 1994;40:79–85
  48. Everts ME, Lim CF, Moerings EPCM, et al. Effects of a furan fatty acid and indoxyl sulfate on thyroid hormone uptake in cultured anterior pituitary cells. American Journal of Physiology. 1995;268:E974–E979
  49. Wassen FWJS, Moerings EPCM, van Toor H, et al. Thyroid hormone uptake in cultured rat anterior pituitary cells: effects of energy status and bilirubin. Journal of Endocrinology. 2000;165:599–606
  50. Everts ME, Docter R, van Buuren JC, et al. Evidence of carrier-mediated uptake of triiodothyronine in cultured anterior pituitary cells of euthyroid rats. Endocrinology. 1993;132:1278–1285
  51. Everts ME, Docter R, Moerings EP, et al. Uptake of thyroxine in cultured anterior pituitary cells of euthyroid rats. Endocrinology. 1994;134:2490–2497
  52. Everts ME, Visser TJ, Moerings EPCM, et al. Uptake of triiodothyroacetic acid and its effect on thyrotropin secretion in cultured anterior pituitary cells. Endocrinology. 1994;135:2700–2707
  53. Lanni A, Moreno M, Lombardi A, et al. Rapid stimulation in vitro of rat liver cytochrome oxidase activity by 3,5-diiodo-L-thyronine and by 3,3′-diiodo-L-thyronine. Molecular and Cellular Endocrinology. 1994;99:89–94
  54. LoPresti JS, Dlott RS. Augmented conversion of T3 to TRIAC (T3AC) is the major regulator of the low T3 state in fasting men. Thyroid. 1992;2:S-39;(Abstract)
  55. Pinna G, Meinhold H, Hiedra L. et al Elevated 3,5-diiodothyronine concentrations in the sera of patients with nonthyroidal illnesses and brain tumors. The Journal of Clinical Endocrinology and Metabolism. 1997;82:1535–1542
  56. Carlin K, Carlin S. Possible etiology for euthyroid sick syndrome. Medical Hypotheses. 1993;40:38–43
  57. Everts ME, Visser R, Moerings EPCM, et al. Uptake of 3,3′,5,5′-tetraiodothyroacetic acid and 3,3′,5′-triiodothyronine in cultured rat anterior pituitary cells and their effects on thyrotropin secretion. Endocrinology. 1994;136:4454–4461
  58. Everts ME, de Jong M, Lim CF, et al. Different regulation of thyroid hormone transport in liver and pituitary: its possible role in the maintenance of low T3 production in nonthyroidal illness and fasting in man. Thyroid. 1996;6:359–369
  59. Danforth E. Effects of fasting and altered nutrition on thyroid hormone metabolism in man. In:  Hennemann G editors. Thyroid hormone metabolism. New York: Marcel Dekker; 1986;p. 335–358
  60. van der Heyden JTM, Docter R, van Toor H, et al. Effects of caloric deprivation on thyroid hormone tissue uptake and generation of low T3 syndrome. American Journal of Physiology. 1986;251:E156–E163
  61. Bodoky G, Yang ZJ, Meguid MM, et al. Effects of fasting, intermittent feeding, or continuous parenteral feeding on rat brain and liver energy metabolism as assessed by 31P-NMR. Physiology and Behaviour. 1995;58:521–527
  62. Rolleman EJ, Hennemann G, van Toor H, et al. Changes in renal triiodothyronine and thyroxine handling during fasting. European Journal of Endocrinology. 2000;142:125–130
  63. de Jong M, Visser TJ, Bernard BF, et al. Transport and metabolism of iodothyronines in cultured human hepatocytes. The Journal of Clinical Endocrinology and Metabolism. 1993;77:139–143
  64. Everts ME, Visser TJ, van Buuren JCJ, et al. Uptake of triiodothyronine sulfate and suppression of thyrotropin secretion in cultured anterior pituitary cells. Metabolism. 1994;43:1282–1286
  65. Docter R, Friesema ECH, van Stralen PGJ, et al. Expression of the transmembrane thyroid hormone transport protein from rat liver in Xenopus laevis oocytes. Thyroid. 1995;5(Suppl 1):S-203;(Abstract)
  66. Docter R, Friesema ECH, van Stralen PGJ, et al. Expression of rat liver cell membrane transporters for thyroid hormone in Xenopus laevis oocytes. Endocrinology. 1997;138:1841–1846
  67. de Jong M, Docter R, van der Hoek H, et al. Adaptive changes in transmembrane transport and metabolism of triiodothyronine in perfused livers of fed and fasted hypothyroid and hyperthyroid rats. Metabolism. 1994;43:1355–1361
  68. Hennemann G, Krenning EP, Polhuys M, et al. Carrier-mediated transport of thyroid hormone into rat hepatocytes is rate limiting in total cellular uptake and metabolism. Endocrinology. 1986;119:1870–1872
  69. Pontecorvi A, Lakshmanan M, Robbins J. Intracellular transport of 3,5,3′-triiodo-L-thyronine in rat skeletal myoblasts. Endocrinology. 1987;121:2145–2152
  70. Hennemann G, Krenning EP, Bernard B, et al. Regulation of influx and efflux of thyroid hormones: possible physiologic significance of the plasma membrane in the regulation of thyroid hormone activity. Hormonal and Metabolic Research. 1984;14(Suppl):1–6
  71. Halpern J, Hinkle PM. Evidence for an active step in thyroid hormone transport to nuclei: drug inhibition of L-125I-triiodothyronine binding to nuclear receptors in rat pituitary tumor cells. Endocrinology. 1982;110:1070–1072
  72. Vos RA, de Jong M, Bernard HF, et al. Impaired thyroxine and 3,5,3′-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with non-thyroidal illness. The Journal of Clinical Endocrinology and Metabolism. 1995;80:2364–2370
  73. Hennemann G, Vos RA, de Jong M, et al. Decreased peripheral 3,5,3′-triiodothyronine (T3) production from thyroxine (T4): a syndrome of impaired thyroid hormone activation due to transport inhibition of T4 into T3-producing tissues. The Journal of Clinical Endocrinology and Metabolism. 1993;77:1431–1435
  74. Jansen M, Krenning EP, Oostdijk W, et al. Hyperthyroxinemia due to decreased peripheral triiodothyronine production. Lancet. 1982;2:849–851

PII: S1521-690X(07)00029-2

doi: 10.1016/j.beem.2007.03.007

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 2 , Pages 323-338 , June 2007

Article Tools

* Image Usage & Resolution